tiprankstipranks
Biocure Technology Inc (TSE:CURE.X)
CNQX:CURE.X

Biocure Technology Inc (CURE.X) Financial Statements

4 Followers

Biocure Technology Inc Financial Overview

Biocure Technology Inc's market cap is currently ―. The company's EPS TTM is C$-0.018; its P/E ratio is -0.55; Biocure Technology Inc is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -23.75KC$ -3.98MC$ -113.16KC$ 2.68MC$ -82.25K
EBITDAC$ -23.75KC$ -3.98MC$ -113.16KC$ 2.68MC$ -82.25K
Net Income Common StockholdersC$ -23.75KC$ -4.01MC$ -113.16KC$ 2.62MC$ -313.17K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 3.53KC$ 4.24KC$ 5.46KC$ 11.65KC$ 10.79K
Total AssetsC$ 1.98MC$ 1.98MC$ 3.50MC$ 3.59MC$ 2.05M
Total DebtC$ 43.67KC$ 41.88KC$ 85.45KC$ 83.96KC$ 82.54K
Net DebtC$ 40.15KC$ 37.64KC$ 79.99KC$ 72.30KC$ 71.74K
Total LiabilitiesC$ 399.21KC$ 373.24KC$ 909.85KC$ 891.88KC$ 4.29M
Stockholders EquityC$ 1.58MC$ 1.60MC$ 2.59MC$ 2.70MC$ -2.24M
Cash Flow-
Free Cash FlowC$ -705.00C$ 49.70KC$ -6.19KC$ -13.86KC$ -246.77K
Operating Cash FlowC$ -705.00C$ 49.70KC$ -6.19KC$ -13.86KC$ -246.77K
Investing Cash Flow---C$ 19.94KC$ 23.37K
Financing Cash Flow-C$ -50.00K-C$ -6.04KC$ 196.43K
Currency in CAD

Biocure Technology Inc Earnings and Revenue History

Biocure Technology Inc Debt to Assets

Biocure Technology Inc Cash Flow

Biocure Technology Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis